Acetazolamide: a treatment for chronic mountain sickness - Wikidata - wikimedia - TriplyDB

Acetazolamide: a treatment for chronic mountain sickness

Acetazolamide: a treatment for chronic mountain sickness

http://www.wikidata.org/entity/Q28269409

about

Prevalence of Chronic Mountain Sickness in high altitude districts of Himachal Pradesh Decreased plasma soluble erythropoietin receptor in high-altitude excessive erythrocytosis and Chronic Mountain Sickness Alterations in cerebral blood flow and cerebrovascular reactivity during 14 days at 5050 m.Altered iPSC-derived neurons' sodium channel properties in subjects with Monge's disease.Suppression of erythropoiesis by dietary nitrate.Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma New genetic and physiological factors for excessive erythrocytosis and Chronic Mountain Sickness High-altitude Pulmonary Hypertension: an Update on Disease Pathogenesis and Management Sleep-disordered breathing and oxidative stress in preclinical chronic mountain sickness (excessive erythrocytosis)Effect of acetazolamide and gingko biloba on the human pulmonary vascular response to an acute altitude ascent.Chronic Mountain Sickness: Clinical Aspects, Etiology, Management, and Treatment Plasma soluble erythropoietin receptor is decreased during sleep in Andean highlanders with Chronic Mountain Sickness Cerebral pressure-flow relationship in lowlanders and natives at high altitude Low-dose acetazolamide in the treatment of premenstrual dysphoric disorder: a case series.Altitude mountain sickness among tourist populations: a review and pathophysiology supporting management with hyperbaric oxygen.Ventilatory oscillations at exercise: effects of hyperoxia, hypercapnia, and acetazolamide.Regional cerebral blood flow in humans at high altitude: gradual ascent and 2 wk at 5,050 m.Worsening of central sleep apnea at high altitude--a role for cerebrovascular function.High-altitude adaptation in humans: from genomics to integrative physiology.Acetazolamide for Monge's disease: efficiency and tolerance of 6-month treatment.Serum testosterone levels and score of chronic mountain sickness in Peruvian men natives at 4340 m.Influence of high altitude on cerebral blood flow and fuel utilization during exercise and recovery.Intracellular pH Regulation in iPSCs-derived Astrocytes from Subjects with Chronic Mountain Sickness.Protective effects of traditional Tibetan medicine Zuo-Mu-A Decoction () on the blood parameters and myocardium of high altitude polycythemia model rats.Preparation for high altitude expedition and changes in cardiopulmonary and biochemical laboratory parameters with ascent to high altitude in transplant patients and live donors.Excessive Erythrocytosis and Cardiovascular Risk in Andean Highlanders High-altitude medicine Lung disease at high altitude Synthesis and Evaluation of New Phthalazine Urea and Thiourea Derivatives as Carbonic Anhydrase Inhibitors

P2860

Q28240895-A6771432-E8C1-4915-955B-2BAA45763B52 Q34626922-3C246451-36CB-464F-8282-F57AC20A1358 Q34641257-32884D30-968A-4489-98FD-CA5DA75200FB Q35071063-FBEB91DD-C490-4A78-91D7-C199015230D6 Q35576516-12E84F94-044B-4721-BB78-A8835F66DD01 Q36290436-F6654B31-73B0-4EEF-8D50-3D92D0965674 Q36382218-826379C2-0798-4879-9939-B8D59DA18090 Q36658602-C72FE971-F0E8-4405-A3B4-8CFBECE557BC Q36736012-2C8023EB-F8A6-4032-9F97-954F654D6F4D Q36960179-E8610F11-8E5E-455E-BAF0-07DF0D65F224 Q37020004-B018990F-01AA-48DA-A3CC-4CD4BE143546 Q37139761-8688D696-2E4A-4508-8806-E07B2B905C23 Q37559282-C34746FC-44BA-44E0-8460-CE0F5B1B6B3E Q37617314-96C8F2AB-7013-4B7E-873F-2B6E0CAEB376 Q37788266-6AE32EAC-E624-490F-ABFB-8EE92593588C Q42120765-D201DEB2-B72F-402F-8337-81B1CC975593 Q45265171-B5977C98-F0AA-48FD-9A94-420719EDA933 Q45344902-F7CDCF26-9DC8-45F3-85CE-60C6EED8D54F Q46659572-660FBB8F-9320-4FD2-A9FE-7EBDDF1938EF Q46664619-534639EC-9906-42B9-943E-4C116DF64B04 Q48307821-AD3561B5-EF6B-48FD-99A9-D51F1930F68D Q48468855-115BBE5D-447B-426C-9AEC-FDF1EF1C1742 Q50039225-1B648ADE-5D5E-435E-A285-82B69FF4DB0F Q50241556-496FC01B-F306-467D-9F20-DA50E220C461 Q51598754-CC71C95B-9334-42F3-A07D-82C2D8C22E90 Q57091674-B30A1266-E561-4081-BDC2-7417601D3872 Q57098063-779A253C-2DE8-4C9D-89F7-64EE1E4CC2D1 Q57102069-65DD96A3-43E9-4536-AE80-BB260E794FBD Q59011135-6390880E-84A4-407A-B821-B90AE539D2D9

P2860

Acetazolamide: a treatment for chronic mountain sickness

http://www.wikidata.org/entity/Q28269409

description

2005 nî lūn-bûn

@nan

2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Acetazolamide: a treatment for chronic mountain sickness

@ast

Acetazolamide: a treatment for chronic mountain sickness

@en

Acetazolamide: a treatment for chronic mountain sickness

@nl

type

label

Acetazolamide: a treatment for chronic mountain sickness

@ast

Acetazolamide: a treatment for chronic mountain sickness

@en

Acetazolamide: a treatment for chronic mountain sickness

@nl

prefLabel

Acetazolamide: a treatment for chronic mountain sickness

@ast

Acetazolamide: a treatment for chronic mountain sickness

@en

Acetazolamide: a treatment for chronic mountain sickness

@nl

P1433

Q28269409-911FE426-214D-470D-B3D9-F5CBCF3D7FFA

P1476

Q28269409-061636CB-5439-407E-AC71-8FC7030A9747

P2093

Q28269409-0B9B8B5C-94F9-4B96-895D-426B1DC91ADC

Q28269409-1210187E-89E7-4C33-97E2-2BA3B6F44FEC

Q28269409-36889A86-99AB-4CFA-A96C-F0908DB3FA58

Q28269409-3CF35BCC-36C5-4E6D-8509-74A3E1AEACC9

Q28269409-41A37A46-E911-4AFB-A226-39A0E42A7720

Q28269409-545CB099-4BDD-4E00-ABEC-D41E41C8686C

Q28269409-79761F1C-7528-45E5-9DE2-0B0E1C8F0CDF

Q28269409-C73A95BB-3B5A-4825-9A6E-0C537351D563

Q28269409-E8C3E2FD-14DD-40A1-9BC6-29E8E7052E7F

Q28269409-FF3CDB8E-70B6-413E-A33D-044BA2E8871E

P304

Q28269409-052DCFF8-1D78-49C5-94EF-FBB2B9A95D8B

P31

Q28269409-9E7788F8-3835-4A18-B012-94073778C12D

P3181

Q28269409-158D99D8-8F06-47B6-AC6B-43FBA7A5EEED

P356

Q28269409-6A533B5E-9555-4BDB-A329-CAB55C4386D2

P407

Q28269409-D556636F-EA9B-40B2-B52A-615EFCA39C79

P433

Q28269409-07999B88-93FC-4818-839C-F574D92E64BB

P478

Q28269409-9A2B3F8E-89CB-40F3-8448-443FF2E4C7DD

P577

Q28269409-FE67B8E0-0BD8-41BA-9DA5-F14D14D99D4C

P698

Q28269409-A4E1DFF3-6D73-4015-9DAF-778C3E058C88

P3181

P356

RCCM.200505-807OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Acetazolamide: a treatment for chronic mountain sickness

@en

P2093

Annick Bienvenu

http://www.w3.org/2001/XMLSchema#string

Eduardo Chirinos

http://www.w3.org/2001/XMLSchema#string

Fabiola León-Velarde

http://www.w3.org/2001/XMLSchema#string

Francçoise Lasne

http://www.w3.org/2001/XMLSchema#string

Igor Onnen

http://www.w3.org/2001/XMLSchema#string

Jean-Paul Richalet

http://www.w3.org/2001/XMLSchema#string

Maria Rivera

http://www.w3.org/2001/XMLSchema#string

Olivier Petitjean

http://www.w3.org/2001/XMLSchema#string

Patrick Bouchet

http://www.w3.org/2001/XMLSchema#string

Stéphane Moutereau

http://www.w3.org/2001/XMLSchema#string

P304

1427-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1408199

http://www.w3.org/2001/XMLSchema#string

P356

10.1164/RCCM.200505-807OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

172

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16126936

http://www.w3.org/2001/XMLSchema#string